IL6 and central nervous system cancer: These data recapitulated the in vitro observations and showed that anti-IL6 therapy could be utilized for the treatment of glioma patients by antagonizing hypoxia-induced autophagy and promoting the apoptosis of tumor cells in hypoxic regions (Fig. 12).